Revenio Group Oyj (HEL:REG1V)

Market Cap	764.72M
Revenue (ttm)	106.32M
Net Income (ttm)	19.10M
Shares Out	26.60M
EPS (ttm)	0.71
PE Ratio	40.25
Forward PE	31.41
Dividend	0.40 (1.43%)
Ex-Dividend Date	Apr 11, 2025

Volume	15,639
Average Volume	18,479
Open	28.05
Previous Close	28.00
Day's Range	27.95 - 28.75
52-Week Range	21.35 - 35.84
Beta	1.48
RSI	66.78
Earnings Date	Apr 29, 2025

About Revenio Group Oyj

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pressure (IOP); iCare TONOVET Pro, a tonometer designed for use in surgical or emergency settings; and iCare TONOVET Plus tonometer, which is used for mea...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 241
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: REG1V

Financial Performance

In 2024, Revenio Group Oyj's revenue was 103.82 million, an increase of 7.27% compared to the previous year's 96.79 million. Earnings were 18.50 million, a decrease of -3.20%.